| Financial Year |
March 31 2023 |
| Monetary Funds |
9,157,554,638.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
120,389,338.01 |
| Accounts Receivable |
2,930,404,855.87 |
| Advances to Suppliers |
707,638,080.45 |
| Other Receivables |
263,577,061.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,441,381,451.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
252,790,656.18 |
| Other Current Assets |
615,009,471.13 |
| Total Current Assets |
21,642,563,075.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
72,957,709.93 |
| Long-term Equity Investment |
343,849,215.53 |
| Investment Properties |
110,703,400.04 |
| Fixed Assetes |
17,945,652,566.14 |
| Under-construction Projects |
6,405,220,131.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,950,159,264.59 |
| R&D expenses |
-- |
| Goodwill |
6,120,076,331.84 |
| Long-Term Deferred and Prepaid Expenses |
115,163,998.14 |
| Deferred Income Tax Assets |
433,106,306.56 |
| Other Non-Current Assets |
1,090,428,171.75 |
| Sub-Total of Non-Current Assets |
39,643,661,818.68 |
| Total Assets |
61,286,224,893.89 |
| Short-Term Loans |
6,905,785,362.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,953,894,143.38 |
| Accounts Payable |
5,001,968,628.83 |
| Accounts Received In Advance |
1,233,095.81 |
| Employee Compensation Payable |
200,458,513.13 |
| Taxes Payable |
315,069,854.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,485,321,240.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,114,746,928.77 |
| Other Current Liabilities |
96,826,606.61 |
| Sub-Total of Current Liabilities |
25,552,709,674.59 |
| Long-term Loans |
10,453,633,415.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
41,678,685.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
101,448,217.39 |
| Deferred Income Tax Liabilities |
949,328,008.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,788,118,872.72 |
| Total Liabilities |
37,340,828,547.31 |
| Paid-In Capital(Or Share Stock) |
2,389,266,956.00 |
| Capital Surplus |
14,578,457,369.50 |
| Surplus Reserve |
1,195,072,628.00 |
| LESS:Treasury Stock |
1,400,283,728.00 |
| Undistributed Profits |
4,547,981,495.86 |
| Minority Stockholder's Interest |
2,488,217,481.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,457,178,865.55 |
| Owner's Equity（Stockholder's Equity） |
23,945,396,346.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
61,286,224,893.89 |
